Globus Medical, Inc. (NYSE:GMED – Get Free Report) has earned an average recommendation of “Moderate Buy” from the twelve brokerages that are currently covering the company, Marketbeat reports.
Provide ready and sustained health services support and force health protection in support of the Total Force to enable readiness and to conserve the fighting strength while caring for our People ...
Virtu Financial LLC purchased a new stake in Aethlon Medical, Inc. (NASDAQ:AEMD – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund ...
StockStory.org on MSN4d
Q4 Earnings Review: Medical Devices & Supplies - Imaging, Diagnostics Stocks Led by GE HealthCare (NASDAQ:GEHC)Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look ...
Basel Medical Group Ltd engages in the provision of healthcare services in Singapore. The company offers general and subspecialized orthopedic, trauma, sports medicine, and neurosurgical services ...
Showing patients props and other visual aids improves recall of information, motivates patients, said doctors who have ...
Experts discuss how cancer treatment and survivorship can be made more equitable and affordable through advocacy, outreach, and effective communication tools. Beyond Cancer: Caring for Young ...
I felt like I was in medical school. I forced myself not to be squeamish observing an open-heart surgery or a Caesarian procedure. I thank my parents for not imploring that I become a doctor. But they ...
Idexx Laboratories generates substantial recurring revenue as a leader in pet healthcare diagnostics. Historically, it's preferred to use the free cash flow it generates to buy back shares of its ...
A 9-year-old girl in California suddenly died on the way home from the dentist, where she underwent dental surgery and was placed under anesthesia, according to a tragic report. The child appeared ...
SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today reported financial results for the fourth quarter and full year ended December 31, 2024 and revenue outlook ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results